Search Results 981-990 of 17365 for Hormone Transition

  1. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

    Endocrine disorders, that are controlled with replacement hormone therapy. Residual Grade 1 or Grade 2 endocrinopathies from prior immune CPIs may be ...

  2. A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation - Mayo Clinic

    ... hormonal treatment and follicle stimulating hormone (FSH) levels in the postmenopausal range. ... hormonal treatment. All male patients who are sexually ...

  3. Medical Research & Education - Mayo Clinic News Network

    Research. Primary Care — Pharmacist collaboration during care transitions adds measurable value. Joel Streed. December 17, 2020. Science Saturday: Mayo study ...

  4. Endocrinology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  5. A Study to Assess Changes in Sensation Thresholds Before and After Genital Gender Confirmation Surgery - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women - Mayo Clinic

    pharmacological doses of thyroid hormone (causing decline of thyroid stimulating hormone below normal);; calcium supplementation of > 1200 mg/d (within the ...

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Proceedings explores digital transformation of clinical trials featured image. Clinical Trials. Mayo Clinic Proceedings explores digital ...

  8. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

    - Richter's transformation to diffuse large B-cell lymphoma (DLBCL), ... in the absence of volume depletion. - N-terminal pro hormone natriuretic ...

  9. Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    ... Hormone therapy for breast ...cancer, Breast cancer, Lobular carcinoma in situ, Atypical hyperplasia of the breast, Breast cysts and lumps, Fibroadenoma ...